Findings are expected to inform portfolio company's innovative approach to Regenerative Medicine Morphoceuticals Inc., a portfolio company of Juvenescence Ltd., hailed the results of a long-term study
Morphoceuticals Inc., a portfolio company of Juvenescence Ltd., hailed the results of a long-term study published by its founders in Science Advances showing the successful regeneration of limbs in Xenopus laevis (African clawed frog).
/PRNewswire/ Morphoceuticals Inc. hailed the results of a long-term study published by its founders in Science Advances showing the successful regeneration.
/PRNewswire/ Morphoceuticals Inc. hailed the results of a long-term study published by its founders in Science Advances showing the successful regeneration.
Juvenescence Debuts New Product to Aid in Supporting a Healthy Metabolism
Metabolic Switch helps consumers support their healthy aging goals
News provided by
Share this article
Share this article
DOUGLAS, Isle of Man, April 15, 2021 /PRNewswire/ Juvenescence Ltd. (Juvenescence), a life sciences company focused on modifying aging and increasing human health span and longevity, today announced the launch of its first product. Metabolic Switch is an evidence-based, breakthrough C6 Ketone Di-ester drink that, once consumed, puts the consumer in ketosis to promote a healthy metabolism.
Juvenescence Debuts Metabolic Switch to Aid in Supporting a Healthy Metabolism
Juvenescence Debuts Metabolic Switch to Aid in Supporting a Healthy Metabolism